Aldeyra Therapeutics Inc — Quarterly Cash Flow (NASDAQ:ALDX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 104.61 M93.2 M84.96 M77.8 M72.06 M Total liabilities 33.6 M29.6 M29.67 M28.56 M27.81 M Total equity 71 M63.6 M55.29 M49.24 M44.25 M Total liabilities & shareholders' equities 104.61 M93.2 M84.96 M77.8 M72.06 M Total debt 15.03 M15.1 M15.15 M15.2 M15.25 M Net debt -132.74 M-114.67 M-107.45 M-76.05 M-54.79 M

Haberler

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

Aldeyra Therapeutics, 15 milyon dolarlık Hercules kredisini ödedi

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

H.C. Wainwright, FDA engeli sonrası Aldeyra hissesini düşürdü

FDA’dan ret sonrası BTIG, Aldeyra hissesi için Al tavsiyesini korudu

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC, rakip gecikmesi sonrası Bausch & Lomb notunu korudu

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

BTIG’ye Göre Bu Yılın En İyi Sağlık Hisseleri